Need Help?


Genome-Wide Human SNP Array 6.0 or the CytoScan HD array, according to the manufacturer’s instructions (Affymetrix, Santa Clara, CA, USA) now part of Thermo Fisher Scientific (Thermo Fisher Scientific, Inc.)

Request Access

These terms and conditions govern access to the managed access datasets to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions.

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom CRCINA Data Access Commitee grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: CRCINA Data Access Commitee and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. CRCINA Data Access Commitee : CRCINA, INSERM 1232, Data Access Commitee, Stéphane MINVIELLE and Florence MAGRANGEAS. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines ( ) and the Toronto Statement ( This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) ( ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) ( ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify CRCINA Data Access Commitee within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify CRCINA Data Access Commitee prior to any significant changes to the protocol for the Project. 14. The User Institution will notify CRCINA Data Access Commitee as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. CRCINA Data Access Commitee may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than CRCINA Data Access Commitee. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of France.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001005125 Other
ID File Type Size Located in
EGAF00005207670 CEL 55.7 MB
EGAF00005207671 CEL 56.4 MB
EGAF00005207672 CEL 118.1 MB
EGAF00005207673 CEL 111.2 MB
EGAF00005207674 CEL 53.4 MB
EGAF00005207675 CEL 57.2 MB
EGAF00005207676 CEL 72.4 MB
EGAF00005207677 CEL 65.6 MB
EGAF00005207678 CEL 62.7 MB
EGAF00005207679 CEL 133.2 MB
EGAF00005207680 CEL 53.9 MB
EGAF00005207681 CEL 62.3 MB
EGAF00005207682 CEL 60.6 MB
EGAF00005207683 CEL 56.8 MB
EGAF00005207684 CEL 52.3 MB
EGAF00005207685 CEL 51.6 MB
EGAF00005207686 CEL 55.9 MB
EGAF00005207687 CEL 69.0 MB
EGAF00005207688 CEL 59.0 MB
EGAF00005207689 CEL 65.1 MB
EGAF00005207690 CEL 129.2 MB
EGAF00005207691 CEL 53.7 MB
EGAF00005207692 CEL 66.7 MB
EGAF00005207693 CEL 64.1 MB
EGAF00005207694 CEL 67.0 MB
EGAF00005207695 CEL 62.1 MB
EGAF00005207696 CEL 54.3 MB
EGAF00005207697 CEL 61.7 MB
EGAF00005207698 CEL 57.0 MB
EGAF00005207699 CEL 53.7 MB
EGAF00005207700 CEL 56.5 MB
EGAF00005207701 CEL 53.0 MB
EGAF00005207702 CEL 57.7 MB
EGAF00005207703 CEL 51.6 MB
EGAF00005207704 CEL 127.6 MB
EGAF00005207705 CEL 58.4 MB
EGAF00005207706 CEL 58.7 MB
EGAF00005207707 CEL 76.6 MB
EGAF00005207708 CEL 63.7 MB
EGAF00005207709 CEL 56.1 MB
EGAF00005207710 CEL 65.9 MB
EGAF00005207711 CEL 52.4 MB
42 Files (2.8 GB)